Some investigations were even looking for significant dependences between miRNAs and other serological parameters as biomarkers of NAFLD; miR-122 and pro-neurotensin were examined, revealing their notably higher concentrations in NAFLD patients [11]. This evidence concerns the gene NTS and metabolic dysfunction-associated steatotic liver disease.